Wereport a 24-year-old Japanese female hospitalized withjaundice and ascites. She exhibited hepatosplenomegaly, severe liver dysfunction, and slight polycythemia with an increase in serum levels of p-thromboglobin and platelet factor 4. Bone marrow was hypercellular with an increase in progenitor cells. The aggregation response of platelets to ADPand to collagen was markedly increased. Venography revealed narrowed hepatic veins with 'spider web' sign. Liver biopsy revealed hepatic congestion. Budd-Chiari syndrome was diagnosed, and was thought to be due to thrombosis related to myeloproliferative disorder. Liver transplant was successful in relieving symptoms. (Internal Medicine 35: 871-875, 1996) 
Introduction
Patients with Budd-Chiari syndrome present with hepatomegaly, abdominal pain, and ascites (1) . The syndrome is caused by occlusion of the hepatic vein or the inferior vena cava (2) . Etiologic factors mayinclude systemic diseases that induce a hypercoagulable state. Primary myeloproliferative disorders (MPD) , especially polycythemia vera and essential thrombocythemia, and paroxysmal nocturnal hemoglobinemia (PNH) are the most commoncauses of thrombogenic hematological disorders (3, 4) . In Japan, however, the most commonetiology ofBudd-Chiari syndrome is idiopathic membranous obstruction of the inferior vena cava (5) (6) (7) . Wepresent a patient with Budd-Chiari syndrome associated with latent MPD,who demonstrated marked hyperthrombogenesis.
Case Report
For editorial comment, see p 837.
A 24-year-old Japanese woman was hospitalized in July 1991 with a complaint of epigastralgia when she was found to have jaundice, hepatosplenomegaly, and a small amountof ascites. She was found to have thrombocytosis, 12 x 104/|il, in July 1992. She was referred and admitted to our hospital in antibody to hepatitis C virus were negative. Computedtomography of the abdomen revealed hepatosplenomegaly: the caudate lobe was remarkablely swollen (Fig. 1 A) . Cavanography revealed stenosis of the inferior vena cava (IVC), caused by pressure from the caudate lobe (Fig. IB) . Nomembranous obstruction was detected. Venography revealed narrowing of the three hepatic veins on the peripheral side. "Spider web" sign was also noted (Fig. 1C) Figure 1 . A. Abdominal CT of the patient, demonstrating marked hepatosplenomegaly. B. Cavanography showed stenosis of the inferior vena cava in the area of the liver due to pressure from the caudate lobe. There was no membranousobstruction. C. Venography of the right hepatic vein revealed a narrowing of veins on the peripheral side as well as "spider web" sign.
syndrome caused by hepatic venous thrombosis was diagnosed. To clarify the etiology of thrombosis in this patient, serum and bone marrowwere examined. There was a markedincrease in serum levels of (3-thromboglobulin (627 ng/ml; normal range, <52 ng/ml) and platelet factor 4 (281.1 ng/ml; normal range, <20 ng/ml). The aggregation response of platelets to ADPand collagen was markedly activated even at low concentrations of those substances (Fig. 2) . Bone marrow was hypercellular with a marked increase in the number of megakaryocytes (Fig. 3) . Chromosomeanalysis of bone marrow cells showed a normal karyotype. In vitro colony assay of bone marrowcells was performed as previously described (8), demonstrating increases in the myeloid and erythroid progenitors (Table 1 ). These findings suggested that thrombosis might be closely related to hypercoagulability due to myeloproliferative disorder. The patient' s liver dysfunction deteriorated and she experienced abdominal fullness caused by the ascites. Accordingly, she received an orthotopic liver transplant in April 15, 1993 at Princess Alexandra Hospital in Australia. Surgical findings demonstrated a moderate amountof ascites , a prominent collateral network of veins, an enlarged firm liver with enlargement of the caudate lobe, and splenomegaly. There was no thrombosis in the portal vein or inferior vena cava, but blood clots were observed in the right hepatic vein. Histology of the extirpated liver revealed incomplete fibrous obliteration of the lumen of the right hepatic vein with recanalization. Other hepatic veins were completely obliterated by fibrous tissue. The liver exhibited extensive, but not generalized, cirrhosis, with some areas showing marked congestion, sinusoidal dilatation, and atrophy of hepatocytes. The caudate lobe showed hyperplasia of the hepatocytes. Thediagnosis was end-stage cirrhosis secondary to Budd-Chiari syndrome. Ten days after the transplantation, blood flow in the hepatic artery was not detectable by echography and a low density area was found in the S6 segment by dynamic computer tomography. On May 2, 1 993, liver retransplantation was performed due to thrombosis in the hepatic artery and partial liver infarction. After retransplantation, the patient received anticoagulants, aspirin and warfarin, along with immunosuppressive agents, cyclosporine and prednisolone. The administration of hydroxyureawasalso started because the platelet count rose to 1 10 x 104/|LXl. Twoyears after the transplant, the patient's liver function has normalized, however, administration ofhydroxyurea (500 to 1 ,000 mg/day) is required to control the platelet count. The aggregation response of platelets to ADP and collagen has decreased slightly in comparison with that of normal controls (data not shown).
Discussion
Hepatic vein thrombosis can lead to Budd-Chiari syndrome. Light density bone marrow cells obtained from the patient and controls were cultured in the presence ofphytohemagglutinin-stimulated leukocyte conditioned media (PHA-LCM) and 2 U/ml recombinant erythropoietin (Epo, Chugai Co., Tokyo, Japan). Colony formation was scored under an inverted microscope on day 14 after culture. Results show the numbers of each type of colony. Results represent the mean+SDof triplicate cultures containing 5 x 104 cells/ml. BM:bone marrow, BFU-E: burst forming unit-erythroids, CFU-G: colony-forming unit-granulocytes, CFU-M: colony-forming unit-macrophages , CFU-GM: colony-forming units-granulocyte-macrophages , CFU-mix:colony-forming units-mixed.
tions present in patients with MPD,PNH, anti-phospholipid syndrome, antithrombin-3 deficiency, Behcet's disease, systemic lupus erythematosus, pregnancy, intake of oral contraceptives, infection, and malignancy (1, 9) . Some previous reports suggested that the presence of latent MPDsuch as polycythemia vera and essential thrombocythemia,might cause thrombosis (7) (8) (9) (10) . These can lead to the development of hepatic vein thrombosis, however, there are patients whodo not show an increase in peripheral blood cell counts because of splenomegaly. In vitro culture studies of progenitor cells and cytogenetic studies using patient bone marrow cells have proven the presence ofMPD (3, (10) (11) (12) . Platelet IgG Fc receptors may be activated in vivo by high concentrations of circulating immunocomplexes, and a high concentration of (3- thromboglobulin is present ( 10). Vadher et al (1 1) reported one case of essential thrombocythemia with thrombogenic complications despite a normal platelet count. However, the platelet count increased years later. The evaluation of bone marrow by cytogenetic and molecular genetic methods facilitated an early diagnosis of latent thrombocythemia. In the present case, it was difficult to diagnose MPDby peripheral blood findings , however, increases in hematopoietic progenitor cells on in vitro culture study as well as slight increases in blood cell counts such as RBC, WBC,and platelets during her clinical course suggested latent MPD.Amongtypes of MPD,essential thrombocythemia seems to be more likely to explain her disorder than polycythemia vera, since marked thrombocytosis, a platelet count of more than 100 x 104/|Lil, was observed during her clinical course (before admission to our hospital and after liver transplantation). Weobserved findings of a hypercoagulable status in this patient as follows: 1) thrombocytosis and erythrocytosis, 2) increases in serum level of pthromboglobulin and platelet factor-4, 3) a markedly increased response of the platelets to even low concentrations of ADPor collagen. These findings suggested that this hypercoagulable state maybe one of main causes of the hepatic vein thrombosis in this patient. Concerning the reason that the hepatic portion of the inferior vena cava is the most common site of thrombosis or obstruction, there have already been several hypotheses, such as mechanical injury, plebitis, infection, and changes in blood flow and/or blood congestion (13-15). However, it is not certain why thrombosis was found only in the main hepatic vein in this case. It has been discussed whether membranous obstruction of the inferior vena in Budd-Chiari syndrome, which is commonly observed in Japan, is caused by congenital malformation. However, a recent histopathological study of membranous obstruction in patients with Budd-Chiari syndrome showed no malformation in the occluding lesions and suggested thrombosis and its sequelae as the causes of this disorder (16). Thus, in patients with Budd-Chiari syndrome, the underlying hematological disorders should be investigated as well as platelet activation, which can cause thrombotic formation. Liver transplantation has been performed in patients with end-stage liver cirrhosis related to Budd-Chiari syndrome ( 1 7, 18) , however, the development of thrombosis in the transplanted liver has been observed in such patients. Such patients require anticoagulant therapy to prevent thrombosis. In addition, chemotherapy for MPDis thought to reduce the risk of thrombosis by controlling the platelet count ( 1 8) . Hydroxyurea maybe effective in reducing the platelet count and in reducing the risk of thrombosis. In the present patient, the platelet count rose to 120 x 104/jil following liver transplantation. Thus, chemotherapy with hydroxyurea as well as anticoagulants, aspirin and warfarin, were required after the transplant. Liver transplantation followed by treatment to control the hyperthrombogenic factors ultimately proved useful in managing this patient with Budd-Chiari syndrome accompanied by latent MPD.
